What we are looking for: Bristol-Myers Squibb areas of interest include affective disorders, Alzheimer’s disease, atherosclerosis, diabetes, hepatitis, HIV/AIDS, obesity, oncology, rheumatoid arthritis, and solid organ transplantation.

A fast, focused process: Here’s what to expect when you submit your opportunity. You’ll hear from us quickly. And often.

Alliance Management: Alliance Management focuses on the asset first.

Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals (05.09.2007)

Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds (04.26.2007)

Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds (02.26.2007)

Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds (01.11.2007)

Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan (12.27.2006)